A detailed history of Concourse Financial Group Securities, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,503 shares of INCY stock, worth $123,757. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,503
Previous 1,695 11.33%
Holding current value
$123,757
Previous $102,000 2.94%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$57.33 - $68.61 $11,007 - $13,173
-192 Reduced 11.33%
1,503 $99,000
Q2 2024

Jul 23, 2024

BUY
$51.18 - $63.75 $8,547 - $10,646
167 Added 10.93%
1,695 $102,000
Q1 2024

Apr 30, 2024

BUY
$56.55 - $66.59 $6,786 - $7,990
120 Added 8.52%
1,528 $87,000
Q4 2023

Feb 07, 2024

BUY
$52.16 - $64.19 $23,732 - $29,206
455 Added 47.74%
1,408 $88,000
Q3 2023

Oct 25, 2023

BUY
$57.77 - $65.93 $17,331 - $19,779
300 Added 45.94%
953 $55,000
Q2 2023

Aug 10, 2023

BUY
$60.95 - $75.51 $9,386 - $11,628
154 Added 30.86%
653 $40,000
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $9,621 - $11,783
137 Added 37.85%
499 $36,000
Q4 2022

Jan 30, 2023

BUY
$67.18 - $84.11 $10,547 - $13,205
157 Added 76.59%
362 $0
Q2 2022

Aug 09, 2022

BUY
$66.18 - $83.18 $5,559 - $6,987
84 Added 69.42%
205 $16,000
Q1 2022

May 09, 2022

SELL
$66.02 - $79.71 $6,602 - $7,970
-100 Reduced 45.25%
121 $10,000
Q4 2021

Feb 07, 2022

BUY
$63.34 - $74.11 $13,998 - $16,378
221 New
221 $16,000
Q3 2021

Nov 09, 2021

SELL
$68.67 - $84.02 $1,373 - $1,680
-20 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $137,216 - $150,376
-1,718 Reduced 98.85%
20 $0
Q1 2021

May 13, 2021

BUY
$76.02 - $100.5 $47,360 - $62,611
623 Added 55.87%
1,738 $141,000
Q4 2020

Feb 02, 2021

BUY
$80.74 - $97.7 $53,853 - $65,165
667 Added 148.88%
1,115 $97,000
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $36,920 - $47,605
434 Added 3100.0%
448 $40,000
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $1,038 - $1,525
14 New
14 $1,000
Q1 2020

May 13, 2020

BUY
$63.18 - $85.97 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$72.82 - $86.52 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

SELL
$73.52 - $88.7 $4,043 - $4,878
-55 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $3,495 - $4,849
55 New
55 $4,000
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $2,691 - $3,217
-46 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$61.75 - $74.23 $2,840 - $3,414
46 New
46 $3,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.